Xap Therapeutics
Cambridge, GB · 1 known investors
Find your way into Xap Therapeutics
Xap Therapeutics uses genome editing and synthetic biology to engineer a programmable cell-based delivery platform that carries therapeutic payloads such as cytokines, antibodies, and nucleic acids, releasing them upon target recognition. It is developing multi-modal therapies for complex diseases including cancer and autoimmunity.
Investors · 1
In the news
Frequently asked questions
- What does Xap Therapeutics do?
- Xap Therapeutics uses genome editing and synthetic biology to engineer a programmable cell-based delivery platform that carries therapeutic payloads such as cytokines, antibodies, and nucleic acids, releasing them upon target recognition. It is developing multi-modal therapies for complex diseases including cancer and autoimmunity.
- Who are Xap Therapeutics's investors?
- Xap Therapeutics's investors include SR One Capital Management.
- Where is Xap Therapeutics headquartered?
- Xap Therapeutics is headquartered in Cambridge, GB.